NCT04521920 - Providing Suboxone and PrEP Using Telemedicine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

August 30, 2021

Study Completion Date

August 30, 2021

Conditions

Opioid UseOpioid-use DisorderRisk ReductionHiv

Interventions

DRUG

Suboxone

Enrolled participants will be prescribed PrEP and/or Suboxone. Follow up visits will be conducted by telemedicine. We are testing whether telemedicine is a feasible method for follow up.

DRUG

PrEP

Enrolled participants will be prescribed PrEP and/or Suboxone. Follow up visits will be conducted by telemedicine. We are testing whether telemedicine is a feasible method for follow up.

Trial Locations (3)

27701

Duke Department of Population Health Sciences, Durham

28215

Queen City Needle Exchnge, Charlotte

28403

North Carolina Harm Reduction Coalition, Wilmington